share_log

Bellerophon Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-507 Summit LLC(8.4%),Lepercq Capital Management LLC(8.4%), etc.

SEC announcement ·  Jan 26 10:49
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more